Ryuzo Ohno is the President Emeritus of the Aichi Cancer Center in Nagoya and a Professor of Aichi Syukutoku University, Nagoya, Japan, and known throughout the world for clinical trials that have improved the outlook for adult patients with leukemia. He graduated from Nagoya University School of Medicine, Japnan, in 1964. He spent one year at the Wadley Institute of Hematology in Dallas before coming to M.D. Anderson Cancer Center in 1967 for a 2-year fellowship at Developmental Therapeutics. There, Dr. Ohno learned the importance of scientific clinical study from a group of oncology pioneers that included Drs. Emil J. Freireich and Emil Frei III. He returned to Nagoya University in 1969 to begin cancer research that would earn an international reputation for landmark clinical studies in acute adult leukemia. Dr. Ohno led efforts in 1987 to establish the Japan Adult Leukemia Study Group (JALSG) and has been its Chairman till 2005. His more than 300 scientific articles in peer-reviewed journals include milestone reports about the usage of G-CSF in acute myeloid leukemia and the increasing survival of acute promyelocytic leukemia patients treated with all-trans retinoic acid. Dr. Ohno was a Professor at the Department of Medicine at Hamamatsu University School of Medicine from 1993 to 2000, and then he became the Director of Aichi Cancer Center Hospital and 3 years later the President of the Aichi Cancer Center till 2005. He received the 2004 Chunichi Cultural Award as well as The Distinguished Alumnus Award 2004 from M.D. Anderson Cancer Center. He served as the President for both the Japanese Society of Clinical Oncology and the Japanese Society of Clinical Hematology during 2005 and as a Science Council of Japan from 2005 to 2008.
Biography Updated on 11 February 2010